SIRT1: a promising therapeutic target in type 2 diabetes mellitus

References

• Aghasi, M., et al., 2019. Beneficial effects of green cardamom on serum SIRT1, glycemic indices and triglyceride levels in patients with type 2 diabetes mellitus: a randomized double-blind placebo controlled clinical trial. Journal of the science of food and agriculture, 99 (8), 3933–3940.
   PubMed Web of Science ®Google Scholar
• Alicic, R.Z., Rooney, M.T., and Tuttle, K.R., 2017. Diabetic kidney disease: challenges, progress, and possibilities. Clinical journal of the American society of nephrology, 12 (12), 2032–2045.
   PubMed Web of Science ®Google Scholar
• Alves-Fernandes, D.K., and Jasiulionis, M.G., 2019. The role of SIRT1 on DNA damage response and epigenetic alterations in cancer. International journal of molecular sciences, 20 (13), 3153.
   PubMed Web of Science ®Google Scholar
• Asher, G., et al., 2008. SIRT1 regulates circadian clock gene expression through PER2 deacetylation. Cell, 134 (2), 317–328.
   PubMed Web of Science ®Google Scholar
• Bagul, P.K., et al., 2015. Resveratrol ameliorates cardiac oxidative stress in diabetes through deacetylation of NFkB-p65 and histone 3. The journal of nutritional biochemistry, 26 (11), 1298–1307.
   PubMed Web of Science ®Google Scholar
• Bao, L., et al., 2014. Grape seed proanthocyanidin extracts ameliorate podocyte injury by activating peroxisome proliferator-activated receptor-γ coactivator 1α in low-dose streptozotocin-and high-carbohydrate/high-fat diet-induced diabetic rats. Food & function, 5 (8), 1872–1880.
   PubMed Web of Science ®Google Scholar
• Bao, L., et al., 2015. Grape seed procyanidin B2 ameliorates mitochondrial dysfunction and inhibits apoptosis via the AMP-activated protein kinase–silent mating type information regulation 2 homologue 1–PPARγ co-activator-1α axis in rat mesangial cells under high-dose glucosamine. British journal of nutrition, 113 (1), 35–44.
   PubMed Web of Science ®Google Scholar
• Belden, W.J., and Dunlap, J.C., 2008. SIRT1 is a circadian deacetylase for core clock components. Cell, 134 (2), 212–214.
   PubMed Web of Science ®Google Scholar
• Bheereddy, P., et al., 2020. SIRT1 activation by polydatin alleviates oxidative damage and elevates mitochondrial biogenesis in experimental diabetic neuropathy. Cellular and molecular neurobiology, 1–15.
   Web of Science ®Google Scholar
• Bordone, L., et al., 2006. Sirt1 regulates insulin secretion by repressing UCP2 in pancreatic beta cells. PLOS biology, 4 (2), e31.
   PubMed Web of Science ®Google Scholar
• Cai, X., et al., 2016. Grape seed procyanidin B2 protects podocytes from high glucose-induced mitochondrial dysfunction and apoptosis via the AMPK-SIRT1-PGC-1α axis in vitro. Food & function, 7 (2), 805–815.
   PubMed Web of Science ®Google Scholar
• Cai, Y.-Y., et al., 2018. Exendin-4 alleviates diabetic cardiomyopathy in mice by regulating Sirt1/PGC1α. Nan Fang yi ke da xue xue bao, 38 (5), 520–526.
   PubMedGoogle Scholar
• Chandrasekaran, K., et al., 2019. Overexpression of Sirtuin 1 protein in neurons prevents and reverses experimental diabetic neuropathy. Brain, 142 (12), 3737–3752.
   PubMedGoogle Scholar
• Chaurasia, A., Mallya, R., and Khan, T., 2016. Novel therapeutic targets for management of type-2 diabetes mellitus. Immunology‚ Endocrine & Metabolic Agents in Medicinal Chemistry, 16 (1), 18–30.
   Google Scholar
• Chen, B., et al., 2020. MiR-221/SIRT1/Nrf2 signal axis regulates high glucose induced apoptosis in human retinal microvascular endothelial cells. BMC ophthalmology, 20 (1), 300–310.
   PubMed Web of Science ®Google Scholar
• Chen, C., et al., 2020. SIRT1 and aging related signaling pathways. Mechanisms of ageing and development, 187, 111215.
   PubMed Web of Science ®Google Scholar
• Chen, W., et al., 2015. Rhein promotes the expression of SIRT1 in kidney tissues of type 2 diabetic rat. Xi Bao yu Fen zi Mian yi Xue za Zhi, 31 (5), 615–619.
   PubMedGoogle Scholar
• Chen, Y., et al., 2017. Endogenous Nampt upregulation is associated with diabetic nephropathy inflammatory-fibrosis through the NF-κB p65 and Sirt1 pathway; NMN alleviates diabetic nephropathy inflammatory-fibrosis by inhibiting endogenous Nampt. Experimental and therapeutic medicine, 14 (5), 4181–4193.
   PubMed Web of Science ®Google Scholar
• Chen, N., Jiang, K., and Yan, G., 2019. Effect of fenofibrate on diabetic retinopathy in rats via SIRT1/NF-κB signaling pathway. European review for medical and pharmacological sciences, 23 (19), 8630–8636.
   PubMed Web of Science ®Google Scholar
• Chuang, P.Y., et al., 2011. Alteration of forkhead box O (foxo4) acetylation mediates apoptosis of podocytes in diabetes mellitus. PLOS one, 6 (8), e23566.
   PubMed Web of Science ®Google Scholar
• Chuang, P.Y., et al., 2014. In vivo RNA interference models of inducible and reversible Sirt1 knockdown in kidney cells. The American journal of pathology, 184 (7), 1940–1956.
   PubMed Web of Science ®Google Scholar
• Colman, R.J., et al., 2009. Caloric restriction delays disease onset and mortality in rhesus monkeys. Science, 325 (5937), 201–204.
   PubMed Web of Science ®Google Scholar
• Cui, C., Li, Y., and Liu, Y., 2019. Down-regulation of miR-377 suppresses high glucose and hypoxia-induced angiogenesis and inflammation in human retinal endothelial cells by direct up-regulation of target gene SIRT1. Human cell, 32 (3), 260–274.
   PubMed Web of Science ®Google Scholar
• D’Angelo, S., et al., 2021. Sirt1 activity in the brain: simultaneous effects on energy homeostasis and reproduction. International journal of environmental research and public health, 18 (3), 1243.
   PubMed Web of Science ®Google Scholar
• de Kreutzenberg, S.V., et al., 2010. Downregulation of the longevity-associated protein sirtuin 1 in insulin resistance and metabolic syndrome: potential biochemical mechanisms. Diabetes, 59 (4), 1006–1015.
   PubMed Web of Science ®Google Scholar
• Defour, A., et al., 2012. Sirtuin 1 regulates SREBP-1c expression in a LXR-dependent manner in skeletal muscle. PLOS one, 7 (9), e43490.
   PubMed Web of Science ®Google Scholar
• Desai, T., et al., 2019. Pharmacologic or genetic activation of SIRT1 attenuates the fat-induced decrease in beta-cell function in vivo. Nutrition & diabetes, 9 (1), 11–19.
   PubMedGoogle Scholar
• Ding, M., et al., 2015. SIRT1 protects against myocardial ischemia-reperfusion injury via activating eNOS in diabetic rats. Cardiovascular diabetology, 14 (1), 112–143.
   PubMedGoogle Scholar
• Du, Y., et al., 2016. Panax notoginseng saponins protect kidney from diabetes by up-regulating silent information regulator 1 and activating antioxidant proteins in rats. Chinese journal of integrative medicine, 22 (12), 910–917.
   PubMed Web of Science ®Google Scholar
• Duan, J., et al., 2015. Chikusetsu saponin IVa confers cardioprotection via SIRT1/ERK1/2 and Homer1a pathway. Scientific reports, 5 (1), 18115–18123.
   PubMedGoogle Scholar
• Fang, W., et al., 2018. Resveratrol alleviates diabetic cardiomyopathy in rats by improving mitochondrial function through PGC-1α deacetylation. Acta pharmacologica sinica, 39 (1), 59–73.
   PubMed Web of Science ®Google Scholar
• Fröjdö, S., et al., 2011. Phosphoinositide 3-kinase as a novel functional target for the regulation of the insulin signaling pathway by SIRT1. Molecular and cellular endocrinology, 335 (2), 166–176.
   PubMed Web of Science ®Google Scholar
• Fu, B., et al., 2019. Preventive effect of Shenkang injection against high glucose-induced senescence of renal tubular cells. Frontiers of medicine, 13 (2), 267–276.
   PubMed Web of Science ®Google Scholar
• Furlan, A., et al., 2019. Mathematical models converge on PGC1α as the key metabolic integrator of SIRT1 and AMPK regulation of the circadian clock. Proceedings of the national academy of sciences of the United States of America, 116 (27), 13171–13172.
   PubMed Web of Science ®Google Scholar
• Gao, L., et al., 2019. LncRNA HOTAIR functions as a competing endogenous RNA to upregulate SIRT1 by sponging miR-34a in diabetic cardiomyopathy. Journal of cellular physiology, 234 (4), 4944–4958.
   PubMed Web of Science ®Google Scholar
• Gerhart‐Hines, Z., et al., 2007. Metabolic control of muscle mitochondrial function and fatty acid oxidation through SIRT1/PGC-1alpha. The EMBO journal, 26 (7), 1913–1923.
   PubMed Web of Science ®Google Scholar
• Gilbert, R.E., et al., 2015. SIRT1 activation ameliorates hyperglycaemia by inducing a torpor-like state in an obese mouse model of type 2 diabetes. Diabetologia, 58 (4), 819–827.
   PubMed Web of Science ®Google Scholar
• Golbidi, S., et al., 2017. Health benefits of fasting and caloric restriction. Current diabetes reports, 17 (12), 111–123.
   PubMed Web of Science ®Google Scholar
• Gollmer, J., Zirlik, A., and Bugger, H., 2020. Mitochondrial mechanisms in diabetic cardiomyopathy. Diabetes & metabolism journal, 44 (1), 33–53.
   PubMed Web of Science ®Google Scholar
• Goyal, R., and Jialal, I., 2018. Diabetes mellitus type 2.
   Google Scholar
• Group, A.S.C., 2018. Effects of n − 3 fatty acid supplements in diabetes mellitus. New England journal of medicine, 379 (16), 1540–1550.
   PubMed Web of Science ®Google Scholar
• Group, D.P.P.R., 2002. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. New England journal of medicine, 346 (6), 393–403.
   PubMed Web of Science ®Google Scholar
• Hammer, S.S., et al., 2019. Pharmacological and fasting-induced activation of SIRT1/LXRα signaling alleviates diabetes-induced retinopathy. bioRxiv, 871822.
   Google Scholar
• Hasegawa, K., et al., 2008. Sirt1 protects against oxidative stress-induced renal tubular cell apoptosis by the bidirectional regulation of catalase expression. Biochemical and biophysical research communications, 372 (1), 51–56.
   PubMed Web of Science ®Google Scholar
• Hasegawa, K., et al., 2013. Renal tubular Sirt1 attenuates diabetic albuminuria by epigenetically suppressing Claudin-1 overexpression in podocytes. Nature medicine, 19 (11), 1496–1504.
   PubMed Web of Science ®Google Scholar
• Hasegawa, K., et al., 2016. Communication from tubular epithelial cells to podocytes through Sirt1 and nicotinic acid metabolism. Current hypertension reviews, 12 (2), 95–104.
   PubMed Web of Science ®Google Scholar
• Hébert, H.L., et al., 2017. Risk factors for neuropathic pain in diabetes mellitus. Pain, 158 (4), 560–568.
   PubMed Web of Science ®Google Scholar
• Hölscher, M.E., Bode, C., and Bugger, H., 2016. Diabetic cardiomyopathy: does the type of diabetes matter? International journal of molecular sciences, 17 (12), 2136.
   PubMed Web of Science ®Google Scholar
• Hou, S., et al., 2014. The protective effect of glycyrrhizic acid on renal tubular epithelial cell injury induced by high glucose. International journal of molecular sciences, 15 (9), 15026–15043.
   PubMed Web of Science ®Google Scholar
• Hou, S., et al., 2017. Glycyrrhizic acid prevents diabetic nephropathy by activating AMPK/SIRT1/PGC-1α signaling in db/db mice. Journal of diabetes research, 2017, 2865912.
   PubMed Web of Science ®Google Scholar
• Huang, K., et al., 2013. Sirt1 resists advanced glycation end products-induced expressions of fibronectin and TGF-β1 by activating the Nrf2/ARE pathway in glomerular mesangial cells. Free radical biology & medicine, 65, 528–540.
   PubMed Web of Science ®Google Scholar
• Huang, K., Gao, X., and Wei, W., 2017. The crosstalk between Sirt1 and Keap1/Nrf2/ARE anti-oxidative pathway forms a positive feedback loop to inhibit FN and TGF-β1 expressions in rat glomerular mesangial cells. Experimental cell research, 361 (1), 63–72.
   PubMed Web of Science ®Google Scholar
• Hui, X., et al., 2017. Adipocyte SIRT1 controls systemic insulin sensitivity by modulating macrophages in adipose tissue. EMBO reports, 18 (4), 645–657.
   PubMed Web of Science ®Google Scholar
• Hwang, J.S., et al., 2018. Lutein suppresses hyperglycemia‐induced premature senescence of retinal pigment epithelial cells by upregulating SIRT1. Journal of food biochemistry, 42 (3), e12495.
   Web of Science ®Google Scholar
• Iwabu, M., et al., 2010. Adiponectin and AdipoR1 regulate PGC-1alpha and mitochondria by Ca(2+) and AMPK/SIRT1. Nature, 464 (7293), 1313–1319.
   PubMed Web of Science ®Google Scholar
• Jia, Q., et al., 2020. Activating Sirt1 by resveratrol suppresses Nav1.7 expression in DRG through miR-182 and alleviates neuropathic pain in rats. Channels, 14 (1), 69–78.
   PubMed Web of Science ®Google Scholar
• Jia, G., Hill, M.A., and Sowers, J.R., 2018. Diabetic cardiomyopathy: an update of mechanisms contributing to this clinical entity. Circulation research, 122 (4), 624–638.
   PubMed Web of Science ®Google Scholar
• Jiang, T., et al., 2019. Resveratrol inhibits high-glucose-induced inflammatory “metabolic memory” in human retinal vascular endothelial cells through SIRT1-dependent signaling. Canadian journal of physiology and pharmacology, 97 (12), 1141–1151.
   PubMed Web of Science ®Google Scholar
• Kadowaki, T., et al., 2006. Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. The journal of clinical investigation, 116 (7), 1784–1792.
   PubMed Web of Science ®Google Scholar
• Kalliora, C., et al., 2019. Dual PPARα/γ activation inhibits SIRT1-PGC1α axis and causes cardiac dysfunction. JCI Insight, 4 (17), 1–18.
   Web of Science ®Google Scholar
• Karbasforooshan, H., and Karimi, G., 2017. The role of SIRT1 in diabetic cardiomyopathy. Biomedicine & pharmacotherapy, 90, 386–392.
   PubMed Web of Science ®Google Scholar
• Ke, N., et al., 2019. Long noncoding RNA SNHG7 inhibits high glucose-induced human retinal endothelial cells angiogenesis by regulating miR-543/SIRT1 axis. Biochemical and biophysical research communications, 514 (2), 503–509.
   PubMed Web of Science ®Google Scholar
• Kemper, J.K., et al., 2009. FXR acetylation is normally dynamically regulated by p300 and SIRT1 but constitutively elevated in metabolic disease states. Cell metabolism, 10 (5), 392–404.
   PubMed Web of Science ®Google Scholar
• Khan, A., et al., 2017. Visual complications in diabetes mellitus: beyond retinopathy. Diabetic medicine, 34 (4), 478–484.
   PubMed Web of Science ®Google Scholar
• Kida, Y., Zullo, J.A., and Goligorsky, M.S., 2016. Endothelial sirtuin 1 inactivation enhances capillary rarefaction and fibrosis following kidney injury through Notch activation. Biochemical and biophysical research communications, 478 (3), 1074–1079.
   PubMed Web of Science ®Google Scholar
• Kim, M., et al., 2013. Resveratrol prevents renal lipotoxicity and inhibits mesangial cell glucotoxicity in a manner dependent on the AMPK-SIRT1-PGC1α axis in db/db mice. Diabetologia, 56 (1), 204–217.
   PubMed Web of Science ®Google Scholar
• Kitada, M., et al., 2011. Dietary restriction ameliorates diabetic nephropathy through anti-inflammatory effects and regulation of the autophagy via restoration of Sirt1 in diabetic Wistar fatty (fa/fa) rats: a model of type 2 diabetes. Experimental diabetes research, 2011, 908185.
   PubMedGoogle Scholar
• Kitada, M., and Koya, D., 2013. SIRT1 in type 2 diabetes: mechanisms and therapeutic potential. Diabetes & metabolism journal, 37 (5), 315–325.
   PubMedGoogle Scholar
• Kitamura, Y.I., et al., 2005. FoxO1 protects against pancreatic beta cell failure through NeuroD and MafA induction. Cell metabolism, 2 (3), 153–163.
   PubMed Web of Science ®Google Scholar
• Koka, S., et al., 2014. Chronic inhibition of phosphodiesterase 5 with tadalafil attenuates mitochondrial dysfunction in type 2 diabetic hearts: potential role of NO/SIRT1/PGC-1α signaling. American journal of physiology heart and circulatory physiology, 306 (11), H1558–H1568.
   PubMed Web of Science ®Google Scholar
• Kubota, S., et al., 2011. Roles of AMP-activated protein kinase in diabetes-induced retinal inflammation. Investigative ophthalmology & visual science, 52 (12), 9142–9148.
   PubMed Web of Science ®Google Scholar
• Kumar, S., et al., 2017. Sirtuin1-regulated lysine acetylation of p66Shc governs diabetes-induced vascular oxidative stress and endothelial dysfunction. Proceedings of the national academy of sciences of the United States of America, 114 (7), 1714–1719.
   PubMed Web of Science ®Google Scholar
• Kumar, S., and Tikoo, K., 2015. Independent role of PP2A and mTORc1 in palmitate induced podocyte death. Biochimie, 112, 73–84.
   PubMed Web of Science ®Google Scholar
• Larsson, S.C., et al., 2018. Type 1 and type 2 diabetes mellitus and incidence of seven cardiovascular diseases. International journal of cardiology, 262, 66–70.
   PubMed Web of Science ®Google Scholar
• Lee, J.-H., et al., 2009. Overexpression of SIRT1 protects pancreatic beta-cells against cytokine toxicity by suppressing the nuclear factor-kappaB signaling pathway. Diabetes, 58 (2), 344–351.
   PubMed Web of Science ®Google Scholar
• Lee, W.-S., and Kim, J., 2017. Diabetic cardiomyopathy: where we are and where we are going. The Korean journal of internal medicine, 32 (3), 404–421.
   PubMed Web of Science ®Google Scholar
• Li, K., et al., 2019. Tetrahydrocurcumin ameliorates diabetic cardiomyopathy by attenuating high glucose-induced oxidative stress and fibrosis via activating the SIRT1 pathway. Oxidative medicine and cellular longevity, 2019, 6746907.
   PubMed Web of Science ®Google Scholar
• Li, Q., et al., 2016. P66Shc-induced microRNA-34a causes diabetic endothelial dysfunction by downregulating Sirtuin1. Arteriosclerosis, thrombosis, and vascular biology, 36 (12), 2394–2403.
   PubMed Web of Science ®Google Scholar
• Li, X., et al., 2007. SIRT1 deacetylates and positively regulates the nuclear receptor LXR. Molecular cell, 28 (1), 91–106.
   PubMed Web of Science ®Google Scholar
• Li, X., et al., 2017. Publisher correction: Puerarin attenuates diabetic kidney injury through the suppression of NOX4 expression in podocytes. Scientific reports, 7 (1), 18111–18113.
   PubMedGoogle Scholar
• Li, X., et al., 2019. SIRT1 activation promotes angiogenesis in diabetic wounds by protecting endothelial cells against oxidative stress. Archives of biochemistry and biophysics, 661, 117–124.
   PubMed Web of Science ®Google Scholar
• Liang, F., Kume, S., and Koya, D., 2009. SIRT1 and insulin resistance. Nature reviews endocrinology, 5 (7), 367–373.
   PubMed Web of Science ®Google Scholar
• Liu, R., et al., 2014. Role of transcription factor acetylation in diabetic kidney disease. Diabetes, 63 (7), 2440–2453.
   PubMed Web of Science ®Google Scholar
• Liu, Z., et al., 2017. Systematic comparison of 2A peptides for cloning multi-genes in a polycistronic vector. Scientific reports, 7 (1), 2193–2199.
   PubMedGoogle Scholar
• Liu, S., Lin, Y., and Liu, X., 2016. Protective effects of SIRT1 in patients with proliferative diabetic retinopathy via the inhibition of IL-17 expression. Experimental and therapeutic medicine, 11 (1), 257–262.
   PubMed Web of Science ®Google Scholar
• Liu, L., Patel, P., and Steinle, J.J., 2018. PKA regulates HMGB1 through activation of IGFBP-3 and SIRT1 in human retinal endothelial cells cultured in high glucose. Inflammation research, 67 (11–12), 1013–1019.
   PubMed Web of Science ®Google Scholar
• Luo, W., et al., 2019. Blockage of ROS and MAPKs-mediated inflammation via restoring SIRT1 by a new compound LF10 prevents type 1 diabetic cardiomyopathy. Toxicology and applied pharmacology, 370, 24–35.
   PubMed Web of Science ®Google Scholar
• Ma, L., et al., 2016. Sirt1 is essential for resveratrol enhancement of hypoxia-induced autophagy in the type 2 diabetic nephropathy rat. Pathology, research and practice, 212 (4), 310–318.
   PubMed Web of Science ®Google Scholar
• Madeo, F., et al., 2019. Caloric restriction mimetics against age-associated disease: targets, mechanisms, and therapeutic potential. Cell metabolism, 29 (3), 592–610.
   PubMed Web of Science ®Google Scholar
• Maeda, S., et al., 2011. Association between single nucleotide polymorphisms within genes encoding sirtuin families and diabetic nephropathy in Japanese subjects with type 2 diabetes. Clinical and experimental nephrology, 15 (3), 381–390.
   PubMed Web of Science ®Google Scholar
• Maegawa, S., et al., 2017. Caloric restriction delays age-related methylation drift. Nature communications, 8 (1), 511–539.
   PubMedGoogle Scholar
• Majidinia, M., et al., 2016. Downregulation of notch signaling pathway as an effective chemosensitizer for cancer treatment. Drug research, 66 (11), 571–579.
   Web of Science ®Google Scholar
• Michael, L.F., et al., 2001. Restoration of insulin-sensitive glucose transporter (GLUT4) gene expression in muscle cells by the transcriptional coactivator PGC-1. Proceedings of the national academy of sciences of the United States of America, 98 (7), 3820–3825.
   PubMed Web of Science ®Google Scholar
• Miki, T., et al., 2013. Diabetic cardiomyopathy: pathophysiology and clinical features. Heart failure reviews, 18 (2), 149–166.
   PubMed Web of Science ®Google Scholar
• Miranda-Díaz, A.G., et al., 2016. Oxidative stress in diabetic nephropathy with early chronic kidney disease. Journal of diabetes research, 2016, 1–7.
   Web of Science ®Google Scholar
• Mirza-Aghazadeh-Attari, M., et al., 2019. 53BP1: a key player of DNA damage response with critical functions in cancer. DNA repair, 73, 110–119.
   PubMed Web of Science ®Google Scholar
• Mishra, M., Duraisamy, A.J., and Kowluru, R.A., 2018. Sirt1: a guardian of the development of diabetic retinopathy. Diabetes, 67 (4), 745–754.
   PubMed Web of Science ®Google Scholar
• Moin, T., et al., 2018. Review of metformin use for type 2 diabetes prevention. American journal of preventive medicine, 55 (4), 565–574.
   PubMed Web of Science ®Google Scholar
• Mortuza, R., et al., 2013. High glucose induced alteration of SIRTs in endothelial cells causes rapid aging in a p300 and FOXO regulated pathway. PLOS one, 8 (1), e54514.
   PubMed Web of Science ®Google Scholar
• Mortuza, R., Feng, B., and Chakrabarti, S., 2015. SIRT1 reduction causes renal and retinal injury in diabetes through endothelin 1 and transforming growth factor β1. Journal of cellular and molecular medicine, 19 (8), 1857–1867.
   PubMed Web of Science ®Google Scholar
• Motonishi, S., et al., 2015. Sirtuin1 maintains actin cytoskeleton by deacetylation of cortactin in injured podocytes. Journal of the American society of nephrology, 26 (8), 1939–1959.
   PubMed Web of Science ®Google Scholar
• Moynihan, K.A., et al., 2005. Increased dosage of mammalian Sir2 in pancreatic beta cells enhances glucose-stimulated insulin secretion in mice. Cell metabolism, 2 (2), 105–117.
   PubMed Web of Science ®Google Scholar
• Naderi, R., et al., 2020. Tropisetron attenuates pancreas apoptosis in the STZ-induced diabetic rats: involvement of SIRT1/NF-κB signaling. Pharmacological reports, 72 (6), 1657–1665.
   PubMed Web of Science ®Google Scholar
• Nakatani, Y., and Inagi, R., 2016. Epigenetic regulation through SIRT1 in podocytes. Current hypertension reviews, 12 (2), 89–94.
   PubMed Web of Science ®Google Scholar
• Nentwich, M.M., and Ulbig, M.W., 2015. Diabetic retinopathy – ocular complications of diabetes mellitus. World journal of diabetes, 6 (3), 489–499.
   PubMed Web of Science ®Google Scholar
• Nogueiras, R., et al., 2012. Sirtuin 1 and sirtuin 3: physiological modulators of metabolism. Physiological reviews, 92 (3), 1479–1514.
   PubMed Web of Science ®Google Scholar
• Nourazarian, S.M., et al., 2015. Effect of root extracts of medicinal herb Glycyrrhiza glabra on HSP90 gene expression and apoptosis in the HT-29 colon cancer cell line. Asian Pacific journal of cancer prevention, 16 (18), 8563–8566.
   PubMedGoogle Scholar
• Osborne, B., et al., 2016. The role of mitochondrial sirtuins in health and disease. Free radical biology & medicine, 100, 164–174.
   PubMed Web of Science ®Google Scholar
• Oza, M.J., and Kulkarni, Y.A., 2020. Formononetin alleviates diabetic cardiomyopathy by inhibiting oxidative stress and upregulating SIRT1 in rats. Asian Pacific journal of tropical biomedicine, 10 (6), 254.
   Web of Science ®Google Scholar
• Oza, M.J., and Kulkarni, Y.A., 2020. Formononetin ameliorates diabetic neuropathy by increasing expression of SIRT1 and NGF. Chemistry & biodiversity, 17 (6), e2000162.
   PubMed Web of Science ®Google Scholar
• Pan, Q., et al., 2020. Overexpression of histone deacetylase SIRT1 exerts an antiangiogenic role in diabetic retinopathy via miR-20a elevation and YAP/HIF1α/VEGFA depletion. American journal of physiology, endocrinology and metabolism, 319 (5), E932–E43.
   PubMed Web of Science ®Google Scholar
• Paolillo, S., et al., 2019. Diabetic cardiomyopathy: definition, diagnosis, and therapeutic implications. Heart failure clinics, 15 (3), 341–347.
   PubMed Web of Science ®Google Scholar
• Papadimitriou, A., et al., 2015. Theobromine increases NAD+/Sirt-1 activity and protects the kidney under diabetic conditions. American journal of physiology, renal physiology, 308 (3), F209–F225.
   PubMed Web of Science ®Google Scholar
• Park, H.S., et al., 2016. Resveratrol increases AdipoR1 and AdipoR2 expression in type 2 diabetic nephropathy. Journal of translational medicine, 14 (1), 1–13.
   PubMedGoogle Scholar
• Park, Y.J., and Woo, M., 2019. Pancreatic β cells: gatekeepers of type 2 diabetes. The journal of cell biology, 218 (4), 1094–1095.
   PubMed Web of Science ®Google Scholar
• Porte, D., Jr., and Kahn, S.E., 1991. Mechanisms for hyperglycemia in type II diabetes mellitus: therapeutic implications for sulfonylurea treatment—an update. The American journal of medicine, 90 (6), S8–S14.
   Google Scholar
• Qi, F., et al., 2020. MiR-204 inhibits inflammation and cell apoptosis in retinopathy rats with diabetic retinopathy by regulating Bcl-2 and SIRT1 expressions. European review for medical and pharmacological sciences, 24 (12), 6486–6493.
   PubMed Web of Science ®Google Scholar
• Qiao, L., and Shao, J., 2006. SIRT1 regulates adiponectin gene expression through Foxo1-C/enhancer-binding protein alpha transcriptional complex. The journal of biological chemistry, 281 (52), 39915–39924.
   PubMed Web of Science ®Google Scholar
• Rai, E., et al., 2012. The interactive effect of SIRT1 promoter region polymorphism on type 2 diabetes susceptibility in the North Indian population. PLOS one, 7 (11), e48621.
   PubMed Web of Science ®Google Scholar
• Ramsey, K.M., et al., 2008. Age-associated loss of Sirt1-mediated enhancement of glucose-stimulated insulin secretion in beta cell-specific Sirt1-overexpressing (BESTO) mice. Aging Cell, 7 (1), 78–88.
   PubMed Web of Science ®Google Scholar
• Rogacka, D., et al., 2018. Metformin overcomes high glucose-induced insulin resistance of podocytes by pleiotropic effects on SIRT1 and AMPK. Biochimica et biophysica acta, 1864 (1), 115–125.
   Web of Science ®Google Scholar
• Rota, E., and Morelli, N., 2016. Entrapment neuropathies in diabetes mellitus. World journal of diabetes, 7 (17), 342–353.
   PubMed Web of Science ®Google Scholar
• Salminen, A., et al., 2008. SIRT1 longevity factor suppresses NF-kappaB-driven immune responses: regulation of aging via NF-kappaB acetylation? BioEssays, 30 (10), 939–942.
   PubMed Web of Science ®Google Scholar
• Sami, W., et al., 2017. Effect of diet on type 2 diabetes mellitus: a review. International journal of health sciences, 11 (2), 65–71.
   PubMedGoogle Scholar
• Schinner, S., et al., 2005. Molecular mechanisms of insulin resistance. Diabetic medicine, 22 (6), 674–682.
   PubMed Web of Science ®Google Scholar
• Schug, T.T., et al., 2010. Myeloid deletion of SIRT1 induces inflammatory signaling in response to environmental stress. Molecular and cellular biology, 30 (19), 4712–4721.
   PubMed Web of Science ®Google Scholar
• Sergi, C., Shen, F., and Liu, S.-M., 2019. Insulin/IGF-1R, SIRT1, and FOXOs pathways–an intriguing interaction platform for bone and osteosarcoma. Frontiers in endocrinology, 10, 93.
   PubMed Web of Science ®Google Scholar
• Shao, H., et al., 2014. Spinal SIRT1 activation attenuates neuropathic pain in mice. PLoS one, 9 (6), e100938.
   PubMed Web of Science ®Google Scholar
• Shao, Y., et al., 2016. Mir-217 promotes inflammation and fibrosis in high glucose cultured rat glomerular mesangial cells via Sirt1/HIF-1α signaling pathway. Diabetes/metabolism research and reviews, 32 (6), 534–543.
   PubMed Web of Science ®Google Scholar
• Sifuentes-Franco, S., et al., 2018. Oxidative stress, apoptosis, and mitochondrial function in diabetic nephropathy. International journal of endocrinology, 2018, 1875870.
   PubMed Web of Science ®Google Scholar
• Singh, S., et al., 2018. CYP-450 epoxygenase derived epoxyeicosatrienoic acid contribute to reversal of heart failure in obesity-induced diabetic cardiomyopathy via PGC-1 α activation. Cardiovascular pharmacology, 7 (1), 1–23.
   Google Scholar
• Solomon, S.D., et al., 2017. Diabetic retinopathy: a position statement by the American Diabetes Association. Diabetes care, 40 (3), 412–418.
   PubMed Web of Science ®Google Scholar
• Song, Y.S., et al., 2013. Association between low SIRT1 expression in visceral and subcutaneous adipose tissues and metabolic abnormalities in women with obesity and type 2 diabetes. Diabetes research and clinical practice, 101 (3), 341–348.
   PubMed Web of Science ®Google Scholar
• Sosnowska, B., et al., 2017. The sirtuin family members SIRT1, SIRT3 and SIRT6: their role in vascular biology and atherogenesis. Atherosclerosis, 265, 275–282.
   PubMed Web of Science ®Google Scholar
• St-Pierre, J., et al., 2006. Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators. Cell, 127 (2), 397–408.
   PubMed Web of Science ®Google Scholar
• Stünkel, W., et al., 2007. Function of the SIRT1 protein deacetylase in cancer. Biotechnology journal, 2 (11), 1360–1368.
   PubMedGoogle Scholar
• Sulaiman, M., et al., 2010. Resveratrol, an activator of SIRT1, upregulates sarcoplasmic calcium ATPase and improves cardiac function in diabetic cardiomyopathy. American journal of physiology, heart and circulatory physiology, 298 (3), H833–H843.
   PubMed Web of Science ®Google Scholar
• Takeda-Watanabe, A., et al., 2012. SIRT1 inactivation induces inflammation through the dysregulation of autophagy in human THP-1 cells. Biochemical and biophysical research communications, 427 (1), 191–196.
   PubMed Web of Science ®Google Scholar
• Tan, S.Y., et al., 2019. Type 1 and 2 diabetes mellitus: a review on current treatment approach and gene therapy as potential intervention. Diabetes & metabolic syndrome, 13 (1), 364–372.
   PubMed Web of Science ®Google Scholar
• Tang, K., et al., 2017. Transcriptional coactivator p300 and silent information regulator 1 (SIRT1) gene polymorphism associated with diabetic kidney disease in a Chinese cohort. Experimental and clinical endocrinology & diabetes, 125 (8), 530–537.
   PubMed Web of Science ®Google Scholar
• Tang, Q., et al., 2018. Overexpression of miR‐22 attenuates oxidative stress injury in diabetic cardiomyopathy via Sirt 1. Cardiovascular therapeutics, 36 (2), e12318.
   Web of Science ®Google Scholar
• Tesch, G.H., 2017. Diabetic nephropathy – is this an immune disorder? Clinical science, 131 (16), 2183–2199.
   PubMed Web of Science ®Google Scholar
• Thrasher, J., 2017. Pharmacologic management of type 2 diabetes mellitus: available therapies. The American journal of cardiology, 120 (1S), S4–S16.
   PubMedGoogle Scholar
• Tiwari, N., et al., 2014. Therapeutic targets for diabetes mellitus: an update. Clinical pharmacology and biopharmacy, 3 (1), 1.
   Google Scholar
• Tong, P., et al., 2019. LncRNA-MEG3 alleviates high glucose induced inflammation and apoptosis of retina epithelial cells via regulating miR-34a/SIRT1 axis. Experimental and molecular pathology, 107, 102–109.
   PubMed Web of Science ®Google Scholar
• Tu, Y., et al., 2020. Melatonin inhibits Müller cell activation and pro-inflammatory cytokine production via upregulating the MEG3/miR-204/Sirt1 axis in experimental diabetic retinopathy. Journal of cellular physiology, 235 (11), 8724–8735.
   PubMed Web of Science ®Google Scholar
• Umanath, K., and Lewis, J.B., 2018. Update on diabetic nephropathy: core curriculum 2018. American journal of kidney diseases, 71 (6), 884–895.
   PubMed Web of Science ®Google Scholar
• Vahtola, E., et al., 2008. Forkhead class O transcription factor 3a activation and Sirtuin1 overexpression in the hypertrophied myocardium of the diabetic Goto-Kakizaki rat. Journal of hypertension, 26 (2), 334–344.
   PubMed Web of Science ®Google Scholar
• Venkatasubramanian, S., et al., 2016. Effects of the small molecule SIRT1 activator, SRT2104 on arterial stiffness in otherwise healthy cigarette smokers and subjects with type 2 diabetes mellitus. Open heart, 3 (1), e000402.
   PubMed Web of Science ®Google Scholar
• Waldman, M., et al., 2018. PARP-1 inhibition protects the diabetic heart through activation of SIRT1-PGC-1α axis. Experimental cell research, 373 (1–2), 112–118.
   PubMed Web of Science ®Google Scholar
• Waldman, M., et al., 2018. Regulation of diabetic cardiomyopathy by caloric restriction is mediated by intracellular signaling pathways involving ‘SIRT1 and PGC-1α. Cardiovascular diabetology, 17 (1), 1–12.
   PubMedGoogle Scholar
• Wang, F., et al., 2019. A SIRT1 agonist reduces cognitive decline in type 2 diabetic rats through antioxidative and anti-inflammatory mechanisms. Molecular medicine reports, 19 (2), 1040–1048.
   PubMed Web of Science ®Google Scholar
• Wang, X., et al., 2017. Resveratrol ameliorates hyperglycemia-induced renal tubular oxidative stress damage via modulating the SIRT1/FOXO3a pathway. Diabetes research and clinical practice, 126, 172–181.
   PubMed Web of Science ®Google Scholar
• Wang, X., et al., 2019. The zinc transporter Slc39a5 controls glucose sensing and insulin secretion in pancreatic β-cells via Sirt1- and Pgc-1α-mediated regulation of Glut2. Protein & cell, 10 (6), 436–449.
   PubMed Web of Science ®Google Scholar
• Wang, X-l., et al., 2016. SIRT1 activator ameliorates the renal tubular injury induced by hyperglycemia in vivo and in vitro via inhibiting apoptosis. Biomedicine & pharmacotherapy, 83, 41–50.
   PubMed Web of Science ®Google Scholar
• Wang, Y., et al., 2018. Role of p53/miR-155-5p/sirt1 loop in renal tubular injury of diabetic kidney disease. Journal of translational medicine, 16 (1), 146–149.
   PubMedGoogle Scholar
• Wątroba, M., and Szukiewicz, D., 2016. The role of sirtuins in aging and age-related diseases. Advances in medical sciences, 61 (1), 52–62.
   PubMed Web of Science ®Google Scholar
• Wu, L., et al., 2012. The effect of resveratrol on FoxO1 expression in kidneys of diabetic nephropathy rats. Molecular biology reports, 39 (9), 9085–9093.
   PubMed Web of Science ®Google Scholar
• Wu, S.Y., et al., 2019. SIRT1 activation promotes β-cell regeneration by activating endocrine progenitor cells via AMPK signaling-mediated fatty acid oxidation. Stem cells, 37 (11), 1416–1428.
   PubMed Web of Science ®Google Scholar
• Xie, J., Zhang, X., and Zhang, L., 2013. Negative regulation of inflammation by SIRT1. Pharmacological research, 67 (1), 60–67.
   PubMed Web of Science ®Google Scholar
• Xiong, Y., Fang, W.-J., and He, Z.-M., 2020. 458-P: resveratrol attenuates diabetic cardiomyopathy by inhibiting asymmetric dimethylarginine-induced PGC-1a acetylation. Diabetes, 69 (Supplement 1), 458-P.
   Google Scholar
• Xu, X., et al., 2016. Puerarin, isolated from Pueraria lobata (Willd.), protects against diabetic nephropathy by attenuating oxidative stress. Gene, 591 (2), 411–416.
   PubMed Web of Science ®Google Scholar
• Xue, M., et al., 2018. High glucose up-regulates microRNA-34a-5p to aggravate fibrosis by targeting SIRT1 in HK-2 cells. Biochemical and biophysical research communications, 498 (1), 38–44.
   PubMed Web of Science ®Google Scholar
• Yang, J., et al., 2020. LncRNA MIR497HG inhibits proliferation and migration of retinal endothelial cells under high-level glucose treatment via miRNA-128-3p/SIRT1 axis. European review for medical and pharmacological sciences, 24 (11), 5871–5877.
   PubMed Web of Science ®Google Scholar
• Yang, S., et al., 2017. Probucol ameliorates renal injury in diabetic nephropathy by inhibiting the expression of the redox enzyme p66Shc. Redox biology, 13, 482–497.
   PubMed Web of Science ®Google Scholar
• Yerra, V.G., Kalvala, A.K., and Kumar, A., 2017. Isoliquiritigenin reduces oxidative damage and alleviates mitochondrial impairment by SIRT1 activation in experimental diabetic neuropathy. The journal of nutritional biochemistry, 47, 41–52.
   PubMed Web of Science ®Google Scholar
• Yeung, F., et al., 2004. Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase. The EMBO journal, 23 (12), 2369–2380.
   PubMed Web of Science ®Google Scholar
• Ying, Y., et al., 2019. Phloretin protects against cardiac damage and remodeling via restoring SIRT1 and anti-inflammatory effects in the streptozotocin-induced diabetic mouse model. Aging, 11 (9), 2822–2835.
   PubMedGoogle Scholar
• Yoshizaki, T., et al., 2009. SIRT1 exerts anti-inflammatory effects and improves insulin sensitivity in adipocytes. Molecular and cellular biology, 29 (5), 1363–1374.
   PubMed Web of Science ®Google Scholar
• Yousefi, B., et al., 2015. Differential effects of peroxisome proliferator-activated receptor agonists on doxorubicin-resistant human myelogenous leukemia (K562/DOX) cells. Cellular and molecular biology, 61 (8), 118–122.
   PubMed Web of Science ®Google Scholar
• Yousefi, B., et al., 2016. Peroxisome proliferator-activated receptors and their ligands in cancer drug-resistance: opportunity or challenge. Anti-cancer agents in medicinal chemistry, 16 (12), 1541–1548.
   PubMed Web of Science ®Google Scholar
• Yuan, Q., et al., 2014. Advanced glycation end-products impair Na+/K+-ATPase activity in diabetic cardiomyopathy: role of the adenosine monophosphate-activated protein kinase/sirtuin 1 pathway. Clinical and experimental pharmacology & physiology, 41 (2), 127–133.
   PubMed Web of Science ®Google Scholar
• Yuan, Y., et al., 2016. Regulation of SIRT1 in aging: roles in mitochondrial function and biogenesis. Mechanisms of ageing and development, 155, 10–21.
   PubMed Web of Science ®Google Scholar
• Zaccardi, F., et al., 2016. Pathophysiology of type 1 and type 2 diabetes mellitus: a 90-year perspective. Postgraduate medical journal, 92 (1084), 63–69.
   PubMed Web of Science ®Google Scholar
• Zeng, Y., et al., 2016. The glucagon like peptide 1 analogue, exendin-4, attenuates oxidative stress-induced retinal cell death in early diabetic rats through promoting Sirt1 and Sirt3 expression. Experimental eye research, 151, 203–211.
   PubMed Web of Science ®Google Scholar
• Zeng, Y., et al., 2019. MicroRNA-29b-3p promotes human retinal microvascular endothelial cell apoptosis via blocking SIRT1 in diabetic retinopathy. Frontiers in physiology, 10, 1621.
   PubMed Web of Science ®Google Scholar
• Zhang, J., 2007. The direct involvement of SirT1 in insulin-induced insulin receptor substrate-2 tyrosine phosphorylation. The journal of biological chemistry, 282 (47), 34356–34364.
   PubMed Web of Science ®Google Scholar
• Zhang, L., et al., 2018. Paeonol ameliorates diabetic renal fibrosis through promoting the activation of the Nrf2/ARE pathway via up-regulating Sirt1. Frontiers in pharmacology, 9, 512.
   PubMed Web of Science ®Google Scholar
• Zhang, S., et al., 2012. SIRT1 is required for the effects of rapamycin on high glucose-inducing mesangial cells senescence. Mechanisms of ageing and development, 133 (6), 387–400.
   PubMed Web of Science ®Google Scholar
• Zhang, T., et al., 2019. Resveratrol ameliorates podocyte damage in diabetic mice via SIRT1/PGC-1α mediated attenuation of mitochondrial oxidative stress. Journal of cellular physiology, 234 (4), 5033–5043.
   PubMed Web of Science ®Google Scholar
• Zhang, T.H., et al., 2018. Gastrodin inhibits high glucose-induced human retinal endothelial cell apoptosis by regulating the SIRT1/TLR4/NF-κBp65 signaling pathway. Molecular medicine reports, 17 (6), 7774–7780.
   PubMed Web of Science ®Google Scholar
• Zhang, Y., et al., 2018. SIRT1 activation attenuates α cell hyperplasia, hyperglucagonaemia and hyperglycaemia in STZ-diabetic mice. Scientific reports, 8 (1), 13910–13972.
   PubMedGoogle Scholar
• Zhang, Z., et al., 2019. Sirtuin 1 alleviates diabetic neuropathic pain by regulating synaptic plasticity of spinal dorsal horn neurons. Pain, 160 (5), 1082–1092.
   PubMed Web of Science ®Google Scholar
• Zhao, S., et al., 2015. Fenofibrate suppresses cellular metabolic memory of high glucose in diabetic retinopathy via a sirtuin 1-dependent signalling pathway. Molecular medicine reports, 12 (4), 6112–6118.
   PubMed Web of Science ®Google Scholar
• Zhao, S., et al., 2016. miR-23b-3p induces the cellular metabolic memory of high glucose in diabetic retinopathy through a SIRT1-dependent signalling pathway. Diabetologia, 59 (3), 644–654.
   PubMed Web of Science ®Google Scholar
• Zheng, Y., Ley, S.H., and Hu, F.B., 2018. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nature reviews endocrinology, 14 (2), 88–98.
   PubMed Web of Science ®Google Scholar
• Zhou, C.-H., et al., 2017. SIRT1 attenuates neuropathic pain by epigenetic regulation of mGluR1/5 expressions in type 2 diabetic rats. Pain, 158 (1), 130–139.
   PubMed Web of Science ®Google Scholar
• Zhou, L., et al., 2015. High glucose induces renal tubular epithelial injury via Sirt1/NF-kappaB/microR-29/Keap1 signal pathway. Journal of translational medicine, 13 (1), 312–352.
   PubMedGoogle Scholar
• Zhou, L., et al., 2018. Long non-coding RNA MALAT1 interacts with transcription factor Foxo1 to regulate SIRT1 transcription in high glucose-induced HK-2 cells injury. Biochemical and biophysical research communications, 503 (2), 849–855.
   PubMed Web of Science ®Google Scholar
• Zhuo, L., et al., 2011. NAD blocks high glucose induced mesangial hypertrophy via activation of the sirtuins-AMPK-mTOR pathway. Cellular physiology and biochemistry, 27 (6), 681–690.
   PubMedGoogle Scholar